中国神经再生研究(英文版) ›› 2024, Vol. 19 ›› Issue (9): 2050-2056.doi: 10.4103/1673-5374.390953

• 原著:脊髓损伤修复保护与再生 • 上一篇    下一篇

鹰嘴豆芽素A可通过抑制氧化应激和炎症小体减轻早期脊髓损伤

  

  • 出版日期:2024-09-15 发布日期:2024-01-26

Biochanin A attenuates spinal cord injury in rats during early stages by inhibiting oxidative stress and inflammasome activation

Xigong Li1, #, Jing Fu2, #, Ming Guan1, Haifei Shi1, Wenming Pan3, *, Xianfeng Lou1, *   

  1. 1Department of Orthopedics, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, China; 2Department of Stomatology, Xixi Hospital, Hangzhou, Zhejiang Province, China; 3Department of Orthopedics, and Spine Surgery, the Affiliated Hospital of Xuzhou Medical School, the Second People’s Hospital of Changshu, Changshu, Jiangsu Province, China
  • Online:2024-09-15 Published:2024-01-26
  • Contact: Xianfeng Lou, MD, Louxianfeng2022@yeah.net; Wenming Pan, MD, panwenming1982@sina.com.
  • Supported by:
    This study was supported by the National Natural Science Foundation of China, Nos. LY20H090018 (to XL) and LY20H060008 (to HS).

摘要:

既往研究显示,具有雌激素样作用的黄酮类化合物,鹰嘴豆芽素A可作为脑缺血再灌注损伤的神经保护剂,但是其对脊髓损伤的作用尚不清楚。实验以重物打击法构建了脊髓损伤大鼠模型,然后连续14d腹腔注射鹰嘴豆芽素A(40mg/kg)进行治疗。结果显示,鹰嘴豆芽素A能有效减轻损伤脊髓神经元和组织损伤,抑制脊髓神经元炎症反应和氧化应激,减少细胞凋亡和焦亡。进一步研究发现,鹰嘴豆芽素A能够抑制损伤脊髓中NLRP3炎症小体ASC,NLRP3和GSDMD的表达以及Toll样受体4/核因子κB通路,激活Nrf2/血红素加氧酶1信号通路以及自噬标志物LC3 II,Beclin-1和P62的表达。且鹰嘴豆芽素A的效果与甲基强的松龙的效果接近。因此提示,鹰嘴豆芽素A通过影响Toll样受体4/核因子κB和Nrf2/血红素加氧酶1信号通路参与其保护脊髓损伤神经细胞的作用,该研究提示,鹰嘴豆芽素A具有治疗改善脊髓损伤的效果。

https://orcid.org/0000-0003-3173-6929 (Xianfeng Lou); https://orcid.org/0009-0007-0866-8127 (Wenming Pan)

关键词: 脊髓损伤, 鹰嘴豆芽素A, 炎症, 氧化应激, 自噬, 凋亡, Nrf2, Toll样受体4, 核因子κB, 血红素加氧酶1

Abstract: Previous studies have shown that Biochanin A, a flavonoid compound with estrogenic effects, can serve as a neuroprotective agent in the context of cerebral ischemia/reperfusion injury; however, its effect on spinal cord injury is still unclear. In this study, a rat model of spinal cord injury was established using the heavy object impact method, and the rats were then treated with Biochanin A (40 mg/kg) via intraperitoneal injection for 14 consecutive days. The results showed that Biochanin A effectively alleviated spinal cord neuronal injury and spinal cord tissue injury, reduced inflammation and oxidative stress in spinal cord neurons, and reduced apoptosis and pyroptosis. In addition, Biochanin A inhibited the expression of inflammasome-related proteins (ASC, NLRP3, and GSDMD) and the Toll-like receptor 4/nuclear factor-κB pathway, activated the Nrf2/heme oxygenase 1 signaling pathway, and increased the expression of the autophagy markers LC3 II, Beclin-1, and P62. Moreover, the therapeutic effects of Biochanin A on early post-spinal cord injury were similar to those of methylprednisolone. These findings suggest that Biochanin A protected neurons in the injured spinal cord through the Toll-like receptor 4/nuclear factor κB and Nrf2/heme oxygenase 1 signaling pathways. These findings suggest that Biochanin A can alleviate post-spinal cord injury at an early stage.

Key words: apoptosis, autophagy, Biochanin A, heme oxygenase 1, inflammation, Nrf2 protein, nuclear factor kappa-B, oxidative stress, spinal cord injury, Toll-like receptor 4